Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, giving promising progress throughout a variety of health-related and industrial applications. With its structural similarity to In a natural way derived human serum albumin, OsrHSA provides a safer, additional reputable substitute for the